Abstract
Nitric oxide and superoxide are free radicals that appear to contribute to the pathogenesis of a number of brain disorders, and cerebral endothelial cells are a potential target of these agents. Because of the capacity for these two agents to combine, it has been suggested that nitric oxide might either enhance or inhibit the toxic effects of superoxide. To establish the effect of the generation of superoxide and nitric oxide alone and in combination, cerebral endothelial cells were exposed to sodium nitroprusside, a source of nitric oxide, and/or paraquat, a source of superoxide. Paraquat enhanced the toxicity of sodium nitroprusside, as did diethyldithiocarbamate, an inhibitor of superoxide dismutase, which supports the hypothesis that enhanced levels of superoxide can combine with nitric oxide to form a more toxic product. Also, the toxicity of paraquat could be partially inhibited by blocking endogenous nitric oxide synthesis using NG-monomethyl-l-arginine. When ascorbate was administered along with sodium nitroprusside to increase nitric oxide generation, as little as 5 μM sodium nitroprusside was toxic when superoxide dismutase was inhibited. Whereas concentrations of 50 to 500 μM sodium nitroprusside and 0.4 mM ascorbate caused ∼100% toxicity, there was no measurable toxicity when these doses were accompanied by 2 mM glutathione or 50 U/ml of catalase; this suggests that peroxides may also contribute to nitric oxide toxicity. These results suggest that the simultaneous generation of nitric oxide and superoxide is synergistic, resulting in enhanced toxicity.
Footnotes
-
Send reprint requests to: Glenn T. Gobbel, D.V.M., Ph.D., Brain Tumor Research Center, Dept. of Neurological Surgery, Box 0520, 505 Parnassus Ave., University of California, San Francisco, CA 94143.
-
↵1 This work was supported by the American Brain Tumor Association and by grants CA 13525, NS 14543, NS 25372 and AG 08938 from the National Institutes of Health.
- Abbreviations:
- ANOVA
- analysis of variance
- BCA
- bathocuproinedisulfonic acid
- DDC
- diethyldithiocarbamate
- GSHpx
- glutathione peroxidase
- GSH
- reduced glutathione
- GSSG
- oxidized glutathione
- LDH
- lactate dehydrogenase
- NMDA
- N-methyl-d-aspartate
- NMMA
- NG-monomethyl-l-arginine
- PBS
- phosphate-buffered saline
- SIN-1
- 3-morpholinosydnonimine
- SNP
- sodium nitroprusside
- SOD
- Cu,Zn-superoxide dismutase
- SNAP
- S-nitroso-N-acetyl-dl-penicillamine
- Received November 18, 1996.
- Accepted May 27, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|